PUBLISHER: Grand View Research | PRODUCT CODE: 1630970
PUBLISHER: Grand View Research | PRODUCT CODE: 1630970
The global wearable artificial kidney market size is expected to reach USD 853.3 million by 2030, registering a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from renal failure and technical advantages of artificial organs are anticipated to boost market growth.
Kidney failure, also known as End Stage Kidney Disease (ESRD), occurs when the organ is unable to filter waste from blood owing to several factors such as toxic environmental pollutants, glomerulonephritis, and high blood pressure. According to the National Kidney foundation (NKD), 10% of the global population is affected by chronic kidney disease (CKD) and millions of people die due to their inability to afford treatment. Thus, increasing number of patients suffering from CKD is driving the market.
At present, there are three major firms that have developed successful prototypes of wearable artificial kidney (WAK): Blood Purification Technologies Inc.; AWAK Technologies; and Dutch Kidney Foundation. The WAK prototypes designed and patented by these firms have been approved for human clinical trials by the U.S. FDA in 2016 with great success. Prior to that, WAK had been successfully tested in the E.U since 2013. WAK products, being in stage of product refinement, are refined at design and utility areas, allowing for greater patient comfort and ease of operation.